Comparison of Ticagrelor with Clopidogrel on Coronary Microvascular Dysfunction Following Acute Myocardial Infarction Using Angiography-Derived Index of Microcirculatory Resistance-Reference-Cited by-同舟云学术

Comparison of Ticagrelor with Clopidogrel on Coronary Microvascular Dysfunction Following Acute Myocardial Infarction Using Angiography-Derived Index of Microcirculatory Resistance

Published:2024-09-02 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Fang Jiacheng,Zhang Yuxuan,Zheng Yiyue,Chen Delong,Yidilisi Abuduwufuer,Ji Rui,Xiang Jianping,Zhang Xinyi,Jiang Jun^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10557-024-07619-4.pdf

Reference29 articles.

1. Tsao CW, Aday AW, Almarzooq ZI et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147(8). https://doi.org/10.1161/CIR.0000000000001123.

2. Neumann F-J, Sousa-Uva M, Ahlsson A et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2). https://doi.org/10.1093/EURHEARTJ/EHY394.

3. Carrick D, Haig C, Ahmed N, et al. Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment-elevation myocardial infarction. Circulation. 2016;134(23):1833–47. https://doi.org/10.1161/CIRCULATIONAHA.116.022603.

4. Canu M, Khouri C, Marliere S, et al. Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: A systematic review and meta-analysis. PLoS ONE. 2022;17(5): e0268330. https://doi.org/10.1371/JOURNAL.PONE.0268330.

5. Hwang D, Park S-H, Koo B-K. Ischemia with nonobstructive coronary artery disease: concept, assessment, and management. JACC Asia. 2023;3(2):169–84. https://doi.org/10.1016/J.JACASI.2023.01.004.